With the dramatic development of molecular diagnostic technologies in recent years, researchers have discovered BRAF, RAS, and telomerase reverse transcriptase (TERT) promoter mutations, RET/PTC rearrangement, and other genetic mutations to be associated with thyroid cancers (27, 28). The gene discussed is BRAF; the disease is thyroid gland carcinoma.